Combining certain inorganic nanoparticles with IL13Ra2 antibodies demonstrates targeted anti-glioma activity against glioma cells; such strategies include high-performance nano-biocatalysts and biocompatible magnetic vortex discs [54,55]. The gene discussed is IL13RA2; the disease is central nervous system cancer.